Interspecialty Opioid Prescribing Patterns in Ophthalmology Following Declaration of a Public Health Emergency
Journal of Ocular Pharmacology and Therapeutics · 2024
DOI: 10.1089/jop.2023.0078 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Hassaam S Choudhry und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Ophthalmology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Purpose
Previous literature has investigated opioid prescription trends in ophthalmology at large, however, little has been done looking at differences between subspecialties. We evaluate if significant trends exist among subspecialties in opioid prescribing patterns. This study aims to illuminate potential over-usage of opioids in ophthalmology that could compromise patient quality of life.
Methods
Medicare data and "National Plan and Provider Enumeration System (NPPES) Downloadable File" were queried for cases of ophthalmologists with nonsuppressed opioid prescription data from 2014 to 2019. Ophthalmologists with no subspecialty code or missing regional, gender, degree, or graduation information were excluded. Chi-squared analysis, analysis of variance, t-tests, and multivariate logistic regression were utilized.
Results
Five thousand one hundred forty-three physician records were included in analysis, 450 of which were by cornea subspecialists. Most cornea cases were male, graduated before 2005, and practiced in the South. All subspecialties had a significantly increased likelihood of making opioid claims and higher prescription rates compared with cornea (P < 0.050) besides glaucoma (P = 0.357). Only oculoplastics had significantly increased likelihood of greater total supply of opioids compared with cornea (odds ratio [OR] = 22.195, 95% confidence interval [CI] = 12.209-40.350, P < 0.001), while pediatrics (OR = 4.036, 95% CI = 1.377-11.831, P = 0.011) and neuro-ophthalmology (OR = 4.158, 95% CI = 1.237-13.975, P = 0.021) in addition to oculoplastics (OR = 64.380, 95% CI = 26.306-157.560, P < 0.001) were predicted to have significantly greater opioid beneficiaries. Males, the South/Midwest, and graduating before 2005, all were generally associated with increased likelihood of greater total opioid claims, supply, beneficiaries, and prescription rate (P < 0.050).
Conclusion
Subspecialty, demographic, chronological, and regional trends exist for opioid prescribing patterns in ophthalmology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Rutgers The State University of New Jersey, Piscataway, New Jersey, USA.
- Bascom Palmer Eye Institute at the University of Miami, Coral Gables, Florida, USA.
ORCID-Profile: Hassaam S Choudhry, Sri Guttikonda
Zitieren
APA
Choudhry, H. S., Patel, A. M., Zhu, A., Guttikonda, S., Shaikh, A., Sadek, H. S., Seery, C. W., & Dastjerdi, M. H. (2024). Interspecialty Opioid Prescribing Patterns in Ophthalmology Following Declaration of a Public Health Emergency. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0078
Vancouver
Choudhry HS, Patel AM, Zhu A, Guttikonda S, Shaikh A, Sadek HS, et al. Interspecialty Opioid Prescribing Patterns in Ophthalmology Following Declaration of a Public Health Emergency. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2023.0078
BibTeX
@article{Choudhry2024,
author = {Choudhry, Hassaam S and Patel, Aman M and Zhu, Aretha and Guttikonda, Sri and Shaikh, Anam and Sadek, Hadeel S and Seery, Christopher W and Dastjerdi, Mohammad H},
title = {Interspecialty Opioid Prescribing Patterns in Ophthalmology Following Declaration of a Public Health Emergency},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
doi = {10.1089/jop.2023.0078}
}
EUVIMED